Andris Elksnis
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets.
Journal: Free radical research
Published: November 16, 2023
Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes.
Journal: Biomedicines
Published: November 30, 2021
Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.
Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.
Journal: Biomedicines
Published: September 28, 2021
GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes.
Journal: BMJ open diabetes research & care
Published: June 22, 2021
Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.
Journal: Clinical science (London, England : 1979)
Published: June 08, 2021
Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass.
Journal: Frontiers in physiology
Published: October 23, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026